Recruiting studies: Pulmonary Hypertension Interstitial Lung Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND PO
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06917196 An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Phase N/A · 23 location(s) · Liquidia Technologies, Inc. · NCT06129240 A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Int
Phase 2 · 19 location(s) · AllRock Bio, Inc. · NCT07175038 The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
NA · 1 location(s) · University of Rochester · NCT07561034 129Xe MRI Cardiopulmonary
Phase 2 · 1 location(s) · Bastiaan Driehuys · NCT06038630 Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Phase 1 · 1 location(s) · Mario Castro, MD, MPH · NCT04624490 Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) P
Phase 3 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT07613099 Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Phase N/A · 1 location(s) · ChromX Health · NCT06528418 Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Phase 2 · 16 location(s) · Tectonic Operating Company, Inc. · NCT07473700 A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Phase 3 · 16 location(s) · Liquidia Technologies, Inc. · NCT07285655 Taiwan Interstitial Lung Disease Multi-center Investigation and Registry
Phase N/A · 1 location(s) · Taichung Veterans General Hospital · NCT06476470 Point-of-care Ultrasound Abnormalities in Eclampsia
NA · 1 location(s) · University of Cape Town · NCT05678062 A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Phase 2 · 1 location(s) · Pulmovant, Inc. · NCT07333183 DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease
Phase N/A · 67 location(s) · United Therapeutics · NCT06388421 Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)
Phase 2 · 9 location(s) · Foresee Pharmaceuticals Co., Ltd. · NCT06475781 Pulmonary Hypertension SOLAR
Phase 2 · 1 location(s) · Bastiaan Driehuys · NCT04778046 Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Phase 2 · 3 location(s) · Paul Szabolcs · NCT03630211 Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease
NA · 30 location(s) · Tempus AI · NCT06911632 Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT07254338 LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Phase 2 · 3 location(s) · OrphAI Therapeutics · NCT05798923 Feasibility of Semaglutide in Advanced Lung Disease
Phase 1/Phase 2 · 1 location(s) · University of Pennsylvania · NCT05746039 Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension
Phase 3 · 109 location(s) · Insmed Incorporated · NCT07179380

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.